IP Group Plc

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures).



Share this project

The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK’s largest growth EIS fund manager which backs world-changing technologies emerging from the UK’s leading universities and research institutions.

We’re one of the most active investors in university and other research-based companies in the world, with a proven track-record in backing and nurturing science and technology-based businesses to deliver impact alongside returns. We’re committed to backing and supporting businesses that bring about a better future for people and planet – companies whose products and services meaningfully contribute to a healthier, tech-enriched; and regenerative future.

Since pioneering the IP model more than two decades ago, we’ve built up a considerable knowledge bank and honed our approach to ensure all stakeholders benefit from the work we do through our portfolio companies.

Why IP Group?

  • Track record
  • Portfolio – access to the best science
  • Permanent capital structure
  • Impact
  • Expertise
  • Global group

Key Figures:

  • IP Group has been a leading driver of scientific investment for over 20 years. We have invested over £1.2 billion in UK early-stage scientific development, fueling the creation of three unicorns, and helping the companies we have backed to create more than 10,000 jobs.
  • IP Group owns Parkwalk, the UK’s largest growth EIS fund manager, which has raised over £400m and backed more than 150 university spin outs across the UK.
  • Together, we work at the cutting edge of life sciences, deeptech and cleantech. We’re scientists, innovators and practitioners with in-field experience and insight.
  • Together, we have backed over 500 science-based companies which are delivering ground-breaking innovation – from Ceres and Oxford Nanopore, to investments such as Istesso, First Light Fusion, Featurespace and Oxbotica.

Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.